Drugs / ADC3680B
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01173770 | Jul 2010 → Feb 2011 | — | Pulmagen Therapeutics | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01448954 | Sep 2011 → Feb 2012 | allergic asthma | Pulmagen Therapeutics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ADC3680B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01173770 ↗ |
| Route | Oral | “ADC3680B Administered Orally” NCT01173770 ↗ |